Showing results (1391-1400 of 3,014) with videos related to

Sort By:
Pageof 302
International Journal of Molecular Sciences|September 28, 2023
Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and DegradationIoanna Barla, Panagiotis Efentakis, Sofia Lamprou, et al.
Heart (British Cardiac Society)|August 8, 2014
Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experienceGerhard-Paul Diller, Alexander Kempny, Ryo Inuzuka, et al.
Journal of Geriatric Oncology|December 9, 2014
Do elderly patients with non-small cell lung cancer get the best out of recent advances in first-line treatment? A comparative study in two tertiary cancer centers in GreeceMarios Bakogeorgos, Giannis Mountzios, Evangelos Bournakis, et al.
Critical Care Medicine|October 26, 2013
Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients*Stijn Blot, Despoina Koulenti, George Dimopoulos, et al.
Oncotarget|May 1, 2018
Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependentEleni-Dimitra Papanagnou, Evangelos Terpos, Efstathios Kastritis, et al.
Plos Neglected Tropical Diseases|October 14, 2009
Mosquito infection responses to developing filarial wormsSara M Erickson, Zhiyong Xi, George F Mayhew, et al.
Case Reports in Neurological Medicine|September 10, 2016
Colon Adenoma Implicating Myasthenia Gravis: A Case Report of a Patient with Postcolectomy ComplicationsY Papachatzakis, E Tseliou, I Tatouli, et al.
Plos One|June 20, 2017
Outcome of cardiac surgery in patients with congenital heart disease in England between 1997 and 2015Aleksander Kempny, Konstantinos Dimopoulos, Anselm Uebing, et al.
Journal of Hematology & Oncology|April 5, 2018
Response and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide and dexamethasone (Rd) in the phase III ASPIRE studyMeletios Dimopoulos, Michael Wang, Vladimir Maisnar, et al.
Microorganisms|December 31, 2025
An ICU Outbreak Due to Two Populations of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Isolates Belonging to ST11 and ST39 Types, Harbouring Double Carbapenemase GenesOlga Koutsopetra, Sophia Vourli, Georgios Stravopodis, et al.
Pageof 302